Mon historique
Flux RSS
Me connecter
Le portail documentaire DOCautisme
Le portail documentaire DOCautisme se donne l'ambition d’être une référence francophone sur les publications et ressources nationales et internationales consacrées aux Troubles du Spectre de l’Autisme.
Le GNCRA ne saurait être tenu pour responsable de l’utilisation tronquée, erronée ou délétère de toute information trouvée sur le portail DOCautisme.
Le GNCRA vous encourage à prendre connaissance des recommandations de bonne pratique professionnelle émises par la Haute Autorité de Santé.
| Titre : | Lymphocytic Extracellular Signal–Regulated Kinase Dysregulation in Autism Spectrum Disorder (2023) |
| Auteurs : | Craig A. ERICKSON, Auteur ; Charles R. TESSIER, Auteur ; Christina GROSS, Auteur ; Ernest V. PEDAPATI, Auteur ; Logan K. WINK, Auteur ; Kelli C. DOMINICK, Auteur ; Rebecca C. SHAFFER, Auteur ; Hilary ROSSELOT, Auteur ; Michael P. HONG, Auteur ; Andrew P. BANTEL, Auteur ; Elizabeth BERRY-KRAVIS, Auteur ; Paul S. HORN, Auteur ; Ryan E. ADAMS, Auteur ; John A. SWEENEY, Auteur |
| Type de document : | Article : Texte imprimé et/ou numérique |
| Dans : | Journal of the american academy of child and adolescent psychiatry (62(5), mai 2023) |
| Article en page(s) : | p. 582-592.e2 |
| Langues: | Anglais |
| Concepts : | Trouble du spectre de l'autisme ; Exploration biologique ; Lymphocyte ; Enzyme ; Facteur biologique |
| Index. décimale : | AUT.21 (Etiologie biomédicale) |
| Résumé : |
OBJECTIVE : Extracellular signal-regulated kinase (ERK1/2) is a conserved central intracellular signaling cascade involved in many aspects of neuronal development and plasticity. Converging evidence support investigation of ERK1/2 activity in autism spectrum disorder (ASD). We previously reported enhanced baseline lymphocytic ERK1/2 activation in autism, and now we extend our work to investigate the early phase kinetics of lymphocytic ERK1/2 activation in idiopathic ASD.
METHOD : Study participants included 67 individuals with ASD (3-25 years of age), 65 age- and sex-matched typical developing control (TDC) subjects, and 36 age-, sex-, and IQ-matched developmental disability control (DDC) subjects matched to those with ASD and IQ <90. We completed an additional analysis comparing results from ASD, TDC, and DDC groups with data from 37 individuals with Fragile X syndrome (FXS). All subjects had blood lymphocyte samples analyzed by flow cytometry following stimulation with phorbol ester and sequentially analyzed for ERK1/2 activation (phosphorylation) at several time points. RESULTS : The ASD group (mean = 5.81 minutes; SD = 1.5) had a significantly lower (more rapid) mean ERK1/2 T1/2 activation value than both the DDC group (mean = 6.78 minutes; SD = 1.6; p = .00078) and the TDC group (mean = 6.4 minutes; SD = 1.5; p = .025). More rapid ERK1/2 T1/2 activation times did correlate with increased social impairment across all study groups including the ASD cohort. Differences in ERK1/2 T1/2 activation were more pronounced in younger than in older individuals in the primary analysis. The ASD group additionally had more rapid activation times than the FXS group, and the FXS group activation kinetics did not differ from those of the TDC and DDC groups. CONCLUSION : Our findings indicate that lymphocytic ERK1/2 activation kinetics are dysregulated in persons with ASD, marked by more rapid early phase activation. Group differences in ERK1/2 activation kinetics appear to be driven by findings from the youngest children analyzed. Diversity & Inclusion Statement We worked to ensure sex and gender balance in the recruitment of human participants. We actively worked to promote sex and gender balance in our author group. The author list of this paper includes contributors from the location and/or community where the research was conducted who participated in the data collection, design, analysis, and/or interpretation of the work. [résumé d'auteur] |
| Sous-type : | Article |
| Consulter : | https://doi.org/10.1016/j.jaac.2022.09.437 |
